Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by HatrikSeLaineon Aug 07, 2020 11:44am
395 Views
Post# 31379168

RE:Best earnings worst result

RE:Best earnings worst resultAnother item that can't be trusted are the so-called Analyst "revised" estimates for Q3 and Q4 2020.  The company's own guidance is up to $35 M net revenue for Q3 2020 and the EPS estimate has only been revised from 6 cents EPS to only 10 cents.     I've also noted that Q4 2020 EPS estimates have now actually been revised DOWN to only 2 cents.  What a joke!

I also don't buy into this misconception that spikes in revenue due to COVID are only 'temporary'.  A quick scan of the growing numbers in the southern USA and growing reports warning of long-term health implications contradict the 'temporary' argument big time.

I feel sorry for those that panicked out of the stock in the past two days believing all of this garbage.  The pending quarterly EPS numbers will far surpass both useless estimates and I still stand by my prediction of exceeding $20 before year-end.
<< Previous
Bullboard Posts
Next >>